Goulart, H., Kantarjian, H., Sasaki, K., Jain, N., Rausch, C., Kadia, T., DiNardo, C., Daver, N., Pemmaraju, N., Ravandi, F., Montalban-Bravo, G., Garcia-Manero, G., Hammond, D., Swaminathan, M., Khouri, R., Ohanian, M., Garris, R., Short, N., Jabbour, E. (2025). Hyper-CVAD versus hyper-CVAD plus blinatumomab for adult patients with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Blood. https://doi.org/10.1182/blood-2025-1566